Canada markets open in 3 hours 31 minutes

ALX Oncology Holdings Inc. (ALXO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.13+0.13 (+1.63%)
At close: 04:00PM EDT
8.09 -0.04 (-0.49%)
Pre-Market: 05:42AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 423.57M
Enterprise Value 275.84M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.58
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 314.27%
S&P500 52-Week Change 324.13%
52 Week High 317.83
52 Week Low 33.94
50-Day Moving Average 310.12
200-Day Moving Average 311.56

Share Statistics

Avg Vol (3 month) 3841.53k
Avg Vol (10 day) 3970.89k
Shares Outstanding 552.1M
Implied Shares Outstanding 652.1M
Float 821.35M
% Held by Insiders 12.03%
% Held by Institutions 193.99%
Shares Short (Jun 28, 2024) 45.51M
Short Ratio (Jun 28, 2024) 44.75
Short % of Float (Jun 28, 2024) 418.50%
Short % of Shares Outstanding (Jun 28, 2024) 410.58%
Shares Short (prior month May 31, 2024) 42.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.78%
Return on Equity (ttm)-82.16%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-166.2M
Diluted EPS (ttm)-3.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)157.44M
Total Cash Per Share (mrq)3.02
Total Debt (mrq)16.84M
Total Debt/Equity (mrq)10.26%
Current Ratio (mrq)5.21
Book Value Per Share (mrq)3.27

Cash Flow Statement

Operating Cash Flow (ttm)-140.47M
Levered Free Cash Flow (ttm)-79.92M